1Bremback FH, Schoppmeyer K, Leupold U, et al. A phase Ⅱ polit of 13-cis retinoic acid and interferon-α in patients with advanced pancreatic carcinoma. Cancer, 1998,83( 11 ) :2 317 被引量：1
2Burris HA 3rd, Moore MJ, Andersen J, et al. Improvement in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer. J Clin Oncol, 1997,15(6):2 403 被引量：1
3Androulakis N, Kourousis C, Dimopoulas G, et al. Treatment of pancreatic cancer with docetaxel and granulocyte colony stimulating factor: a multi-center phase Ⅱ study. J Clin Oncol,1999,17(6) :1 779 被引量：1
4Halm U, Schumann T, Schiefke I, et al. Decrease of CA19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer,2000,82 (5): 1 013 被引量：1
5Casper ES, Green MR, Kelsen DP, et al. Phase Ⅱ trial of gemcitabine in patients with adenocarcinoma of the pancreas. Invest New Drugs, 1994,12( 1 ) :29 被引量：1
6Berlin J, Alberti D,Arzoomanian R, et al. Phase I trial of gemcitabine, leucovorin and 5-fluorouracil in patients with advanced malignancy. Invest New Drugs, 1998,16(4) :325 被引量：1
7Philip P,Zalupski M,Vaitkevicius V,et al. Phase Ⅱ study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma. Cancer,2001,92 ( 3 ) :569 被引量：1
6Schima W,Ba-Ssalamah A,Kolblinger c,at al.Pancreatic a denocarcinoma.Eur Radiol,2007,17:638. 被引量：1
7FREELOVE R, WALLING A D. Pancreatic cancer: diagnosis and management [J]. Am ram Physician, 2006, 73 (3): 485-492 被引量：1
8STORNIOLAM, ENASNH, BROWNCA, etal. An investigation news drug treatment program for patients with gemcitabine: results for over 3 000 patients with pancreatic carcinoma [J]. Cancer, 1999, 85 (6) : 1261- 1268 被引量：1
9VAN CUTSEM E, AERTS R , HAUSTERMANS K, et al. Systemic treatment of pancreatic cancer [ J]. Eur J Gastmcnterol Hepatol, 2004, 16:265-274 被引量：1
10HEINEMANN V, QUIETZSCH D, GIESELER F, et al. Randomized phase Ⅲ trial of gemeitabine plus eisplatin compared with gemcitabine alone in advanced pancreatic cancer [J]. J Clin Oncol, 2006, 24 (2) : 3946-3952 被引量：1
